FindMyKOL

Kevin Shiue, MD

Enriched profile

Assistant Professor of Radiation Medicine · Indiana University School of Medicine

ORCID↗NPI↗
✓ Itemized profile
Region🇺🇸 Indianapolis, IN · Midwest · United StatesSpecialtyRadiation OncologyFocusAdvanced Radiotherapy Techniques+4
Active KOLFindMyKOL type: RegionalLatest publicationSee ScholarshipOnline presenceNone verifiedPayments2021–2025NIH fundingNone on fileWhy? →

Kevin Shiue is Assistant Professor of Radiation Medicine at Indiana University School of Medicine. OpenAlex indexes 97 publications with 803 citations (h-index 13); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.

Data verified 7 Nov 2026

Overview

Updated 7 Nov 2026

Kevin Shiue, M.D., is Assistant Professor of Radiation Medicine at Indiana University School of Medicine. The public record shows 97 publications with 803 citations (h-index 13), centered on Advanced Radiotherapy Techniques, Glioma Diagnosis and Treatment, Brain Metastases and Treatment. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 11 companies.

  • Top research focus: Advanced Radiotherapy Techniques
  • 3 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 11 companies

Generated from the cited public record · current as of 7 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Neoplasm Metastasis2 trialsBrain Neoplasms2 trialsLung Cancer (NSCLC/SCLC)1 trialNeuro-Oncology / Glioma1 trialCarcinoma, Small Cell1 trialOvarian / Gynecologic CancerHead & Neck CancerTuberculosisLeukemia (AML/ALL/CML/CLL)Breast CancerAcromegalySarcoma

Research focus

OpenAlex concept fingerprint
Advanced Radiotherapy TechniquesGlioma Diagnosis and TreatmentBrain Metastases and TreatmentManagement of metastatic bone diseaseLung Cancer Diagnosis and Treatment

Drugs & molecules

across trials, industry payments and publications
Cablivigeneric · CaplacizumabClinical trials—Industry payments1Publications—Fabhaltageneric · IptacopanClinical trials—Industry payments1Publications—Kisqaligeneric · RibociclibClinical trials—Industry payments1Publications—Monjuvigeneric · TafasitamabClinical trials—Industry payments1Publications—Monoferricgeneric · Ferric derisomaltoseClinical trials—Industry payments1Publications—Piqraygeneric · AlpelisibClinical trials—Industry payments1Publications—Zoladexgeneric · GoserelinClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Elekta, Inc.Clinical trials—Industry payments3Indiana UniversityClinical trials2Industry payments—Novartis Pharmaceuticals CorporationClinical trials—Industry payments2Novocure Inc.Clinical trials—Industry payments2Adaptive Biotechnologies CorporationClinical trials—Industry payments1Genzyme CorporationClinical trials—Industry payments1GT Medical Technologies, IncClinical trials—Industry payments1icotec Medical Inc.Clinical trials—Industry payments1MorphoSys, US Inc.Clinical trials—Industry payments1NRG OncologyClinical trials1Industry payments—Pharmacosmos Therapeutics Inc.Clinical trials—Industry payments1TerSera Therapeutics LLCClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
97publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

803citations

Citations across these publications.

13h-index

H-index from these publications. i10-index 17.

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials ↓
11companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 7 Nov 2026

Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 7 Nov 2026

11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    58.8%
    Corticosteroid58.8%
    Dexamethasone100%
    Part D≥25 patients
  • Nervous system

    41.2%
    Benzodiazepine41.2%
    Lorazepam100%
    Part D≥23 patients
Where care is delivered (Part B)95.1% facility · 4.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 7 Nov 2026

48 congress contributions (2012–2025) across ASCO, ASTRO, ESTRO Congress, IASLC, SNO per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Network

Updated 7 Nov 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Tim Lautenschlaeger41Gordon A. Watson36Namita Agrawal27Richard Cedric Zellars24Márk Langer20Alberto Cerra-Franco19Gregory K. Bartlett19Shearwood McClelland16Feng‐Ming Kong16Jordan A. Holmes14Susannah G. Ellsworth13Yong Zang12Ryan M. Rhome11James C. Miller9Simon Shek-Man Lo9Aaron P. Kamer9Colleen M. DesRosiers9Mitesh V. Shah8Daniel William Golden8Christina C. Huang7Jian‐Yue Jin7Yongmei Liu7H. Yao6Khalil J. Diab6Neil C. Estabrook6Samuel T. Chao6Jason Hinton6Douglas J. Vile5Allison E. Garda5Aaron Cohen‐Gadol5Thomas J. Birdas5Paul A. Anthony5Yi Le5Homan Mohammadi5Mona Arbab5Donna M. Edwards5Nasser H. Hanna5Weili Wang5Christopher R. Deig5Matthew W. Pease4

Background & recognition

Updated 7 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Case Western Reserve University

    2014
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.iu.edu ↗
  • BS

    Purdue University

    2010
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.iu.edu ↗

Editorial & leadership roles

journal and society appointments
  • Member

    American Society for Radiation Oncology (ASTRO)

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.iu.edu ↗

Awards & honors

honors on the public record
  • Trustees' Teaching Award

    Indiana University

    2023
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.iu.edu ↗

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.